Duo Oncology Signs Exclusive License with University of Pittsburgh

March 17, 2022, 6:00:00 PM

Duo Oncology Continues Development of Cancer Nanomedicine Platform and Products from Dr. Song Li of the Pitt Center for Pharmacogenetics